Full Text View
Tabular View
No Study Results Posted
Related Studies
Biological Aspects of Depression and Antidepressant Drugs
This study has been completed.
Study NCT00018733   Information provided by Department of Veterans Affairs
First Received: July 3, 2001   Last Updated: January 20, 2009   History of Changes

July 3, 2001
January 20, 2009
September 1996
 
 
 
Complete list of historical versions of study NCT00018733 on ClinicalTrials.gov Archive Site
 
 
 
Biological Aspects of Depression and Antidepressant Drugs
Biological Aspects of Depression and Antidepressant Drugs

This study will be measuring changes in depressive symptoms over a 7 week time period. Double-blind placebo controlled trial using the pharmacologic agents Paroxetine or Desipramine.

 
 
Interventional
Treatment, Randomized, Double-Blind, Placebo Control, Pharmacodynamics Study
Depression
  • Drug: paroxetine
  • Drug: Desipramine
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
 
December 2001
 
  • Diagnosis of major depressive disorder Ham-D Score > 18
  • English speaking with ability to read and sign an informed consent
Both
21 Years to 69 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00018733
 
MHBS-031-99F
Department of Veterans Affairs
 
Investigator: Steve Brannan, M.D.
Investigator: Cheryl Gonzalez, M.D.
Department of Veterans Affairs
December 2004

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP